Related Experiment Video

Updated: Aug 11, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers

Herbert J Zeh1, David L Bartlett

  • 1Division of Surgical Oncology, University of Pittsburgh, University of Pittsburgh Cancer Institute, PB02 Cancer Pavilion, Pittsburgh, Pennsylvania 15232, USA.

Cancer Gene Therapy
|January 11, 2003
PubMed

Insights

This study modified vaccinia virus for cancer gene therapy, creating a safe and effective tumor-targeting vector. The engineered virus replicates efficiently in tumors without harming normal tissues, showing promise for treating cancer.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Gene therapy for cancer requires efficient tumor-targeting vectors.
  • Current vectors face limitations in replication, targeting, and safety.
  • Poxviruses, specifically vaccinia virus, are explored as tumor-selective replicating vectors.

Purpose of the Study:

  • To develop a safe and effective tumor-selective replicating vector for cancer gene therapy.
  • To address limitations of current gene therapy vectors.
  • To investigate the potential of a mutated vaccinia virus strain.

Main Methods:

  • Studied poxviruses, specifically a mutated WR strain of vaccinia virus.
  • Engineered the virus by deleting the thymidine kinase (TK) and vaccinia growth factor (VGF) genes.
  • Evaluated the mutant virus's replication efficiency, tumor targeting, and safety in vivo, including systemic delivery in mice.

Main Results:

  • The mutated vaccinia virus demonstrated preserved replication efficiency in tumor tissue.
  • The mutant virus did not cause destruction of normal tissue, enhancing safety.
  • Systemic delivery of the mutant virus successfully treated subcutaneous tumors in mice.

Conclusions:

  • The mutated vaccinia virus is a promising candidate for tumor-directed gene therapy.
  • This vector offers improved safety and efficacy compared to wild-type vaccinia virus.
  • Further clinical trials are planned based on successful preclinical results.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...